NephroGenex (NRX) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts NRX Hot Sheet
Join SI Premium – FREE
NephroGenex (NASDAQ: NRX) reported Q3 EPS of ($0.50), $0.04 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on NephroGenex (NRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
